Managing IP held the second annual MIP IP Enforcement Forum , at Le Méridien Piccadilly, London on October 4 . The MIP IP Enforcement Forum 2017 identified the keys to success in combatting the ever-growing crime of counterfeiting. The forum also took a global look at portfolio management across designs and 3D trade marks, how to successfully enforce a colour mark, and the unique challenges posed by digital health and pharmaceutical branding. The boom of the digital economy posed immense challenges for IP owners, the forum also helped delegates to adapt existing enforcement strategies to incorporate technological developments and limit future infringements in the world of digital transformation.
Delegates attended a full day of debates and discussions to hear from, and network with over 100 leading experts within the life sciences community. All delegates participated to important debates about the most significant developments in the European patent system and the opportunity to contribute as well as learn.
SPEAKING QUERIES Natalie Canter firstname.lastname@example.org +44 207 779 8730 SPONSORSHIP QUERIES Melanie Petch email@example.com +44 207 779 8836 REGISTRATION & MARKETING QUERIES firstname.lastname@example.org +44 207 779 8334
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International